Melanoma subsequent to natalizumab exposure

A report from the RADAR (Research on Adverse Drug events And Reports) program

Ryan C. Kelm, Erika L. Hagstrom, Regine J. Mathieu, Kelsey A. Orrell, Linda Serrano, Kelly A. Mueller, Anne E Laumann, Dennis P West, Beatrice Nardone*

*Corresponding author for this work

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)820-821
Number of pages2
JournalJournal of the American Academy of Dermatology
Volume80
Issue number3
DOIs
StatePublished - Mar 1 2019

Fingerprint

Drug-Related Side Effects and Adverse Reactions
Melanoma
Research
Natalizumab

ASJC Scopus subject areas

  • Dermatology

Cite this

Kelm, Ryan C. ; Hagstrom, Erika L. ; Mathieu, Regine J. ; Orrell, Kelsey A. ; Serrano, Linda ; Mueller, Kelly A. ; Laumann, Anne E ; West, Dennis P ; Nardone, Beatrice. / Melanoma subsequent to natalizumab exposure : A report from the RADAR (Research on Adverse Drug events And Reports) program. In: Journal of the American Academy of Dermatology. 2019 ; Vol. 80, No. 3. pp. 820-821.
@article{b1c54bf1a28649debe83381ae14fabf6,
title = "Melanoma subsequent to natalizumab exposure: A report from the RADAR (Research on Adverse Drug events And Reports) program",
author = "Kelm, {Ryan C.} and Hagstrom, {Erika L.} and Mathieu, {Regine J.} and Orrell, {Kelsey A.} and Linda Serrano and Mueller, {Kelly A.} and Laumann, {Anne E} and West, {Dennis P} and Beatrice Nardone",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.jaad.2018.10.052",
language = "English (US)",
volume = "80",
pages = "820--821",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "3",

}

Melanoma subsequent to natalizumab exposure : A report from the RADAR (Research on Adverse Drug events And Reports) program. / Kelm, Ryan C.; Hagstrom, Erika L.; Mathieu, Regine J.; Orrell, Kelsey A.; Serrano, Linda; Mueller, Kelly A.; Laumann, Anne E; West, Dennis P; Nardone, Beatrice.

In: Journal of the American Academy of Dermatology, Vol. 80, No. 3, 01.03.2019, p. 820-821.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Melanoma subsequent to natalizumab exposure

T2 - A report from the RADAR (Research on Adverse Drug events And Reports) program

AU - Kelm, Ryan C.

AU - Hagstrom, Erika L.

AU - Mathieu, Regine J.

AU - Orrell, Kelsey A.

AU - Serrano, Linda

AU - Mueller, Kelly A.

AU - Laumann, Anne E

AU - West, Dennis P

AU - Nardone, Beatrice

PY - 2019/3/1

Y1 - 2019/3/1

UR - http://www.scopus.com/inward/record.url?scp=85057275766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057275766&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2018.10.052

DO - 10.1016/j.jaad.2018.10.052

M3 - Article

VL - 80

SP - 820

EP - 821

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 3

ER -